Codexis to Participate in Cowen 43rd Annual Health Care Conference
28 February 2023 - 8:05AM
Codexis, Inc. (Nasdaq:CDXS), a leading enzyme engineering company,
today announced that management will participate in both a
panel discussion and a fireside chat at the Cowen 43rd Annual
Health Care Conference, being held March 6-8, 2023, in Boston,
Massachusetts.
Stephen Dilly, MBBS, PhD, President and Chief
Executive Officer of Codexis, will participate in a panel
discussion titled, “SynBio & AI Driven Drug Discovery,” taking
place on Monday, March 6, 2023, at 4:40 pm ET. Dr. Dilly and other
members of the management team will also participate in a fireside
chat taking place on Tuesday, March 7, 2023, at 11:10 am ET.
Webcasts of both events will be available in the Investor Relations
section of the Company’s website, http://ir.codexis.com.The panel
presentation and fireside chat webcasts will be archived for 30 and
90 days, respectively, following the event.
About Codexis
Codexis is a leading enzyme engineering company
leveraging its proprietary CodeEvolver® platform to discover and
develop novel, high performance enzymes and biotherapeutics.
Codexis enzymes have applications in the sustainable manufacturing
of small molecule pharmaceuticals, in RNA and DNA synthesis and the
creation of next generation life science tools, and as gene
therapies and oral enzyme therapies. Codexis’ unique enzymes can
drive improvements such as higher yields, reduced energy usage and
waste generation, improved return on capital in manufacturing,
improved sensitivity in genomic and diagnostic applications, and
more efficacious therapeutics. For more information, visit
www.codexis.com.
Investor Relations Contact:
Argot PartnersBrendan Strong/Carrie McKim(212)
600-1902Codexis@argotpartners.com
Media Relations Contact:
Lauren Musto(781) 572-1147lauren.musto@codexis.com
Codexis (NASDAQ:CDXS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Codexis (NASDAQ:CDXS)
Historical Stock Chart
From Jul 2023 to Jul 2024